Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ryo Morikawa"'
Autor:
Yuki Yonemoto, Yasuhiro Nemoto, Ryo Morikawa, Nana Shibayama, Shigeru Oshima, Takashi Nagaishi, Tomohiro Mizutani, Go Ito, Satoru Fujii, Ryuichi Okamoto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Recent advances in research suggest that aging has a controllable chronic inflammatory disease aspect. Aging systemic T cells, which secrete pro-inflammatory factors, affect surrounding somatic cells, and accelerate the aging process through chronic
Externí odkaz:
https://doaj.org/article/eabcaa9857894d08ba028fb74b77537c
Autor:
Ryo Morikawa, Yasuhiro Nemoto, Yuki Yonemoto, Shohei Tanaka, Yuria Takei, Shigeru Oshima, Takashi Nagaishi, Kiichiro Tsuchiya, Kengo Nozaki, Tomohiro Mizutani, Tetsuya Nakamura, Mamoru Watanabe, Ryuichi Okamoto
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 5, Pp 1483-1503 (2021)
Background & Aims: The reason why small intestinal cancer is rarer than colorectal cancer is not clear. We hypothesized that intraepithelial lymphocytes (IELs), which are enriched in the small intestine, are the closest immune cells to epithelial cel
Externí odkaz:
https://doaj.org/article/c4ff1ba134044ee4a1ca01871d771fcd
Autor:
Satoshi Okazaki, Shuken Boku, Yuichiro Watanabe, Ikuo Otsuka, Tadasu Horai, Ryo Morikawa, Atsushi Kimura, Naofumi Shimmyo, Takaki Tanifuji, Toshiyuki Someya, Akitoyo Hishimoto
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0265738 (2022)
BackgroundMacrophage migration inhibitory factor (MIF) is a multifunctional cytokine that promotes neurogenesis and neuroprotection. MIF is predominantly expressed in astrocytes in the brain. The serum MIF level and microsatellites/single nucleotide
Externí odkaz:
https://doaj.org/article/e3b8d20e652343bd816168d7a3768297
Publikováno v:
IEEJ Transactions on Sensors and Micromachines. 143:110-119
Autor:
MITSUKUNI SUENAGA, SHINICHI YAMAUCHI, RYO MORIKAWA, RIKA NOJI, YOSHIHITO KANO, MASANORI TOKUNAGA, YUSUKE KINUGASA
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1278-1284, 7p
Autor:
Yuki Yonemoto, Yasuhiro Nemoto, Ryo Morikawa, Nana Shibayama, Shigeru Oshima, Takashi Nagaishi, Tomohiro Mizutani, Go Ito, Satoru Fujii, Ryuichi Okamoto
Publikováno v:
Frontiers in Immunology; 2024, p1-15, 15p
Autor:
Tetsuya Nakamura, Kengo Nozaki, Takashi Nagaishi, Shohei Tanaka, Mamoru Watanabe, Shigeru Oshima, Ryuichi Okamoto, Yasuhiro Nemoto, Kiichiro Tsuchiya, Yuria Takei, Ryo Morikawa, Yuki Yonemoto, Tomohiro Mizutani
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 5, Pp 1483-1503 (2021)
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 5, Pp 1483-1503 (2021)
Background & Aims The reason why small intestinal cancer is rarer than colorectal cancer is not clear. We hypothesized that intraepithelial lymphocytes (IELs), which are enriched in the small intestine, are the closest immune cells to epithelial cell
Autor:
Tetsuya Nakamura, Mamoru Watanabe, Ryuichi Okamoto, Kiichiro Tsuchiya, Takashi Nagaishi, Shohei Tanaka, Yasuhiro Nemoto, Yuria Takei, Shigeru Oshima, Ryo Morikawa
Publikováno v:
Biochemical and Biophysical Research Communications. 523:328-335
Intraepithelial lymphocytes (IELs) are very unique in the intestinal immune system. They include γδT cells and CD4–CD8–TCRαβ+T cells (double negative: DNT), both of which are specific for the intestine, in addition to CD4+ and CD8+ T cells. I
Autor:
Ryo Morikawa, Ryuichi Okamoto, Shohei Tanaka, Shigeru Oshima, Yuria Takei, Takashi Nagaishi, Yasuhiro Nemoto, Susanne Stutte, Kiichiro Tsuchiya, Mamoru Watanabe, Tetsuya Nakamura
Publikováno v:
Biochemical and Biophysical Research Communications. 522:971-977
In Japan and other Asian countries, increased fat uptake induced by a westernized diet is thought to be associated with an increased incidence of inflammatory bowel disease, colorectal cancer and food allergies; however, the mechanism for this remain
Autor:
Ryo Morikawa, Kentaro Nitta, Shuntaro Yasuda, Rika Noji, Yoshihito Kano, Shingo Sato, Sadakatsu Ikeda, Masashi Nagata, Takehiko Mori, Mitsukuni Suenaga
Publikováno v:
Journal of Clinical Oncology. 41:791-791
791 Background: Immune checkpoint inhibitors (ICIs) are widely used in tumor-agnostic therapy showing remarkable survival benefit in various cancer types. Gastrointestinal (GI) toxicities are common immune-related adverse events (irAEs) with limited